Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2025
Recommendations for radiotherapy quality assurance in clinical trials.
СтатьяОбзорПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nielsen Camilla Panduro, Samsøe Eva, Offersen Birgitte Vrou, Lorenzen Ebbe Laugaard, Persson Gitte, Mortensen Hanna Rahbek, Nissen Henrik Dahl, Vogelius Ivan Richter, Kallehauge Jesper Folsted, Muren Ludvig Paul, Brincker Mads, Felter Mette van Overeem, Dahlrot Rikke Hedegaard, Hokland Steffen Bjerre, Schytte Tine, Havelund Birgitte Mayland, Weber Britta, Møller Ditte Sloth, Serup-Hansen Eva, Jensen Kenneth, Jakobsen Kirsten Legård, Josipovic Mirjana, Krogh Simon Long, Lukacova Slávka, Hoffmann Lone, Hansen Christian Rønn
Аннотация
Robust quality assurance (QA) of clinical trials in radiotherapy (RT) is paramount for minimising uncertainties in treatment delivery, thereby strengthening the statistical power of the study and increasing the likelihood of accurately answering the research question. As RT techniques evolve and become more complex, establishing an appropriate QA program for a specific clinical trial becomes increasingly challenging, highlighting the importance of clear and standardised recommendations. This study provide such recommendations for Principal Investigators (PIs) to consider when planning and conducting RT Quality Assurance (RTQA) for clinical trials. They arise from experiences with RTQA in the clinical trials conducted in the Danish Multidisciplinary Cancer Groups (DMCGs). The recommendations include a checklist to guide PIs in developing an effective RTQA program.